Discover 133 paid clinical trials in Missoula, Montana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 133
Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare
Making INformed Decisions in Gaze and Postural Stability: A Pilot Feasibility Study
for
Vestibular Hypofunction
Location: Missoula MT
Sponsor: University of Montana
Sex: All
Age: 40+
Code: NCT05391932
Recruiting
Prospective US Radiofrequency SUI Trial
for
Urinary Incontinence, Stress
Location: Missoula MT, Idaho Falls ID, Long Beach CA, Maplewood MN,
Sponsor: Viveve Inc.
Sex: Female
Age: 18+
Code: NCT04720352
Recruiting
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
for
Asthma
Location: Missoula MT, Colorado Springs CO, Bakersfield CA,
Sponsor: GlaxoSmithKline
Sex: All
Age: 12 - 17
Code: NCT05757102
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
By submitting, you consent to the use of your personal details, including contact information and location, to respond to your request for information related to clinical trials, as outlined in the Privacy Policy. If at any time you want to discontinue receiving alerts, please click the Unsubscribe link in the email received.
A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis
for
Plaque Psoriasis
Location: Missoula MT, Mill Creek WA, Portland OR, Thousand Oaks CA,
Sponsor: Amgen
Sex: All
Age: 6 - 17
Code: NCT06088199
Phase3, Recruiting
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
for
Myelodysplastic Syndrome
Location: Missoula MT, Anaconda MT, Kalispell MT, Great Falls MT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06577441
Phase2, Recruiting
A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight